![workplace-with-people-in-walking-in-blurred-motion-in-modern-office-space_AdobeStock_714071973](https://www.nortonrosefulbright.com/-/media/images/nrf/hero/workplace-with-people-in-walking-in-blurred-motion-in-modern-office-space_adobestock_714071973.jpeg?w=265&revision=757b8aa8-f74f-4e2d-9ccd-084ec5192278&revision=5250277392097387904&hash=380B464034E4102358A0D456AAB43445)
Publication
Merger law reform in Australia: What next after the Exposure Draft?
As expected, the Australian Commonwealth Treasury released an exposure draft for the proposed new Australian merger regime on 24 July 2024.
United States | Publication | February 2022
Norton Rose Fulbright lawyers Roger Kuan and Jason Novak contributed several chapters to Digital Health 2022 International Comparative Legal Guide, published by GLG, which is a leading global platform for legal reference, analysis and news. Kuan also served as a contributing editor for the publication.
Authors: Roger Kuan, Norton Rose Fulbright and David Wallace, Johnson & Johnson
As an introduction into digital health, Kuan expands on the digital technologies in healthcare including healthcare IT, data use, data sharing, intellectual property, commercial agreements, AI and machine learning and liability and the acceleration transformation that was experienced during the pandemic.
Authors: Jason Novak, Norton Rose Fulbright and René Quashie, Consumer Technology Association
Novak explores Digital Therapeutics (DTx), an innovative subset of digital health that has quickly become a new platform for addressing treatment, management and prevention of various disease, as well as any legal and regulatory issues that may arise.
Authors: Roger Kuan and Jason Novak, Norton Rose Fulbright
In this chapter, Kuan and Novak provide answers to key questions regarding digital health and emerging technologies.
Publication
As expected, the Australian Commonwealth Treasury released an exposure draft for the proposed new Australian merger regime on 24 July 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023